Bridging gaps in mitochondrial disease diagnosis: the role of advanced biomarker discovery
Open Access
- 31 January 2026
- journal article
- editorial
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 104 (1) , 36
Abstract
No abstract availableFunding Information
- National Research Foundation (SRUG210321590571)
This publication has 32 references indexed in Scilit:
- Disparities in Artificial Intelligence–Based Tools Among Diverse Minority PopulationsJACC: Advances, 2025
- Exploring CSF biomarkers in amyotrophic lateral sclerosis: Highlighting the significance of TDP-43Journal of the Neurological Sciences, 2025
- Fairness in AI for healthcareFuture Healthcare Journal, 2024
- Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature reviewHealth Science Reports, 2024
- Altered markers of mitochondrial function in adults with autism spectrum disorderAutism Research, 2023
- Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's diseaseAlzheimer's & Dementia, 2023
- MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic ArthritisCurrent Rheumatology Reports, 2021
- Sample size calculations for diagnostic studiesClinical Microbiology and Infection, 2019
- In vivo assessment of muscle mitochondrial function in healthy, young males in relation to parameters of aerobic fitnessEuropean Journal of Applied Physiology, 2019
- Surrogate analyte‐based quantification of main endocannabinoids in whole blood using liquid chromatography–tandem mass spectrometryBiomedical Chromatography, 2018